Abstract

Providing Positive Outcomes through Compounding for Animal Cancer Patients

Author(s): Davidson Gigi S

Issue: Jul/Aug 2000 - Compounding for Hospice and Cancer Patients

Page(s): 264-272

Download in electronic PDF format for $75
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 1
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 2
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 3
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 4
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 5
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 6
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 7
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 8
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 9

Abstract

The role of the compounding pharmacist is critical during the treatment of animals with cancer. In this article, the author discusses methods of therapy, considerations for extrapolation of therapies, chemoresponsive tumors (lymphoma, mast cell tumor, osteosarcoma, bladder cancer, postvaccinal sarcomas, equine tumors, sarcoids, squamous cell carcinoma and melanoma), specific intralesional and topical chemotherapy and immunotherapy, adverse sequelae to cancer treatment in animal patients, therapeutic options for pain in the cancer patient and frontiers of veterinary cancer therapy. She also provides tables with the following information: a chart showing conversion of body weight in kilograms to body surface area in meters squared for dogs, a chart showing conversion of body weight in kilograms to body surface area in meters squared for cats, compounded cancer treatment options for oral administration, considerations for extrapolation of human therapies to animal patients, a treatment protocol for canine lymphoma, a feline lymphoma treatment protocol, canine mast cell tumor treatment options, a canine osteosarcoma treatment protocol, a feline vaccine-associated sarcoma treatment protocol, equine sarcoid treatment options, equine squamous cell carcinoma treatment options, equine melanoma treatment options, compounded intralesional and topical chemotherapeutic agents, treatment options for adverse sequelae to cancer treatment and therapeutic options for pain management in the veterinary cancer patient.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2000
Pg. 264-272
Author(s): Davidson Gigi S
Jan/Feb 2009
Pg. 42-49
May/Jun 2005
Pg. 195-198
Author(s): Davidson Gigi S
Jul/Aug 2000
Pg. 257-260
Author(s): Maddox Suzan
Mar/Apr 2004
Pg. 126-129
Author(s): Allen Loyd V Jr
Jan/Feb 2008
Pg. 62
Author(s): Stockton Shelly J
Sep/Oct 2019
Pg. 358-364
May/Jun 2013
Pg. 262-263
Author(s): Williams LaVonn A
Jul/Aug 2012
Pg. 276-286
Author(s): Gaskins Jessica
Jan/Feb 2008
Pg. 16-27
Author(s): Williams LaVonn A
Jul/Aug 2002
Pg. 250-254
Author(s): Zava David T
Jul/Aug 1997
Pg. 242-243
May/Jun 1997
Pg. 175
Author(s): Allen Loyd V Jr
Jul/Aug 1997
Pg. 258
Author(s): Allen Loyd V Jr
Nov/Dec 2006
Pg. 449
Author(s): Stockton Shelly J
Jul/Aug 2015
Pg. 303-305
Author(s): Miller David G
May/Jun 2005
Pg. 178-182
View Sample
Author(s): Davidson Gigi S
Jan/Feb 2021
Pg. 18-23
May/Jun 2005
Pg. 185-192
Nov/Dec 2003
Pg. 490-494